Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.452
- +0.002+0.47%
Trading Mar 11 09:54 ET
115.71MMarket Cap-2.71P/E (TTM)
0.455High0.445Low251.45KVolume0.448Open0.450Pre Close113.21KTurnover0.14%Turnover RatioLossP/E (Static)255.88MShares1.65052wk High1.44P/B78.73MFloat Cap0.44552wk Low--Dividend TTM174.11MShs Float21.570Historical High--Div YieldTTM2.18%Amplitude0.420Historical Low0.450Avg Price1Lot Size
About Adaptimmune Therapeutics Company
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolADAP
Company NameAdaptimmune Therapeutics
Listing DateMay 6, 2015
Issue Price17.00
Founded2014
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000
Websitehttp://www.adaptimmune.com
Company Executives
- Name
- Position
- Salary
- Adrian Rawcliffe
- Director and Chief Executive Officer
- 2.77M
- Dr. Helen Tayton-Martin, PhD
- Chief Business and Strategy Officer
- 1.18M
- Dr. Elliot Norry
- Chief Medical Officer
- 1.18M
- Cintia Piccina
- Chief Commercial Officer
- --
- Gavin Hilary James Wood
- Chief Financial Officer and Principal Accounting Officer
- 1.17M
- John Lunger
- Chief Patient Supply Officer
- --
- William C. Bertrand, Esq.,Jr
- Chief Operating Officer
- 1.22M
- Dr. Joanna Brewer
- Chief Scientific Officer
- --
- David M. Mott
- Chairman of the Board
- 174.83K
- Dr. Priti Hegde, PhD
- Independent Director
- 82.25K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 111.54K
- Dr. Andrew R. Allen, M.D.,PhD
- Independent Director
- 83.50K
- Dr. Kristen M. Hege, M.D.
- Independent Director
- 72.63K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 117.29K
- John P. Furey
- Independent Director
- 117.25K
- Lawrence M. Alleva
- Independent Director
- 128.80K